Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Krystal Biotech | 16 | 0 | 3 | 0 | €145.15 | €173.22 | 19.338% |
| Laboratorios Farmaceuticos | 1 | 0 | 1 | 0 | €84.80 | €100.00 | 17.925% |
| Lisata Therapeutics Inc. | 1 | 0 | 0 | 0 | €2.50 | €4.00 | 60.000% |
| MacroGenics Inc. | 11 | 0 | 3 | 0 | €13.58 | €20.00 | 47.275% |
| MannKind Corp. | 7 | 0 | 0 | 0 | €3.90 | €6.42 | 64.594% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €363.30 | €421.61 | 16.049% |
| Merck & Co. Inc. | 28 | 1 | 5 | 0 | €122.60 | €124.93 | 1.900% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.75 | €65.00 | -4.059% |
| Natural Alternat. | 18 | 1 | 1 | 0 | €6.30 | - | - |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | €1.23 | €3.70 | 201.058% |
| Neurocrine Bioscience | 23 | 0 | 3 | 0 | €127.05 | €137.63 | 8.331% |
| Novartis AG ADR | 1 | 0 | 0 | 0 | €91.00 | - | - |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
| Novo Nordisk A/S ADR | 17 | 1 | 3 | 0 | €119.00 | €130.44 | 9.612% |
| Perrigo Co. plc | 3 | 0 | 1 | 0 | €29.15 | €35.99 | 23.449% |
| Personalis Inc | 5 | 0 | 1 | 0 | €1.18 | €3.23 | 173.164% |
| PharmAust Ltd. | 1 | 0 | 0 | 0 | €0.14 | - | - |
| Precision BioSciences Inc | 6 | 0 | 1 | 0 | €0.35 | €2.81 | 706.293% |
| ProQR Therapeutics N.V. | 6 | 0 | 1 | 0 | €1.89 | €2.81 | 48.695% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Regeneron Pharmaceuticals Inc. | 33 | 1 | 6 | 1 | €825.20 | €957.22 | 15.999% |
| Repligen Corp. | 12 | 0 | 0 | 0 | €154.50 | €182.96 | 18.421% |
| Rhythm Pharmaceuticals | 14 | 0 | 2 | 0 | €36.60 | €46.08 | 25.908% |
| Rigel Pharmaceutical Inc. | 9 | 0 | 0 | 0 | €1.02 | €13.74 | 1243.324% |
| Sanofi S.A. | 4 | 0 | 1 | 0 | €91.85 | €99.50 | 8.329% |